MENU
CAMP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Camp4 Therapeutics (CAMP) Ownership - Who owns Camp4 Therapeutics?
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases... Show more
Profile
Industry
N/A
Address
15635 Alton Parkway
Phone
+1 949 600-5600
Employees
644
Web
https://www.calamp.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
43.14M
P/E Ratio
N/A
Total Cash
2.53M
Projected Growth
0.10
Total Debt
9.45M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.13
Total Debt/Equity
N/A
Revenue/Share
0.14 USD as % of share price
Fundamentals
CAMP
Capitalization
43.1M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
2.53M
Total Cash/Share
0.13
Total Debt
9.45M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.10
Revenue/Share (as % of the share price)
0.14%
Revenue
0
ROE
N/A
Book Value
-158.98M
P/B Ratio
0.74
Cash Flow
N/A
Earnings
-2.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
0.47
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-50.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-241.07
Shares Held By Institutions
65.3M
Shares Outstanding - Current
20.2M
Total Liabilities
180M
Total Volume MTD
N/A
Value
1
Gain YTD
-59.004
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
15635 Alton Parkway
Phone
+1 949 600-5600
Employees
644
Web
https://www.calamp.com